Active Ingredient: CARBIDOPA; LEVODOPA
Proprietary Name: CARBIDOPA AND LEVODOPA
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 25MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075091
Product Number: 002
Approval Date: Apr 21, 2000
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
